Skip to search formSkip to main contentSkip to account menu

Ocupress

National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

CarteololCarteolol Hydrochloride

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
RR 93 - 2014 NATS Naproxeno, Rosilez, Losartan, Sulsotifina, Flexolgin, Ocupress, Codeten, Syslane UL, Cedrilax, Alisquireno e Paroxetina
Review
2007
Review
2007
Ocular Carteolol
SummaryAbstractOcular carteolol (Mikelan®, Teoptic®, Ocupress®) is a nonselective β-adrenoceptor antagonist with intrinsic… 
1997
1997
Daily Cost of β-Adrenergic Blocker Therapy
Objective: To evaluate the daily cost of β-blocker therapy among commercially available products. Methods: Ten different… 
1997
1997
Daily cost of beta-adrenergic blocker therapy.
OBJECTIVE To evaluate the daily cost of beta-blocker therapy among commercially available products. METHODS Ten different beta… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)